The role of topical medications in the management of stasis ulcers.
D000891:Anti-Infective Agents, Local / Q000009:adverse effects*; D001458:Bandages / Q000009:adverse effects*; D001566:Benzocaine / Q000009:adverse effects; D002713:Chlorine / Q000008:administration & dosage / Q000009:adverse effects; D003408:Cresols / Q000008:administration & dosage / Q000009:adverse effects; D003875:Drug Eruptions; D004342:Drug Hypersensitivity; D005029:Ethylenediamines / Q000008:administration & dosage / Q000009:adverse effects; D005840:Gentian Violet / Q000008:administration & dosage / Q000009:adverse effects; D006582:Hexachlorophene / Q000008:administration & dosage / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy*; D009355:Neomycin / Q000008:administration & dosage / Q000009:adverse effects; D009583:Nitrofurazone / Q000008:administration & dosage / Q000009:adverse effects; D009824:Ointments; D010226:Parabens / Q000009:adverse effects; D014677:Pharmaceutical Vehicles; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000009:adverse effects
D000891:Anti-Infective Agents, Local; D003408:Cresols; D005029:Ethylenediamines; D006634:Histamine H1 Antagonists; D009824:Ointments; D010226:Parabens; D014677:Pharmaceutical Vehicles; D000644:Quaternary Ammonium Compounds; D002713:Chlorine; D009355:Neomycin; D006582:Hexachlorophene; D005840:Gentian Violet; D001566:Benzocaine; D009583:Nitrofurazone